CXCL8 and diabetes mellitus: Patients with diabetes who have proliferative retinopathy show heightened levels of inflammatory mediators, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), soluble interleukin-2 receptor (sIL-2R), and interleukin-8 (IL-8) [5].